Rajendran Vivek, Joy Danny, Chandran Biju, Jacob Mathew
Aster Integrated Liver Care, Aster Medcity, Cheranallur, Kochi 682027, India.
J Clin Exp Hepatol. 2025 Mar-Apr;15(2):102445. doi: 10.1016/j.jceh.2024.102445. Epub 2024 Nov 13.
Portal vein thrombosis (PVT) occurs as a part of the natural history of cirrhosis in up to 15% of patients with cirrhosis. In the initial days, PVT was considered a contraindication to liver transplantation, but now with advanced techniques and perioperative management, patients with complex PVT also undergo living-donor liver transplantation (LDLT) with a similar outcome. This review provides a comprehensive overview of methods to proceed with liver transplantation when the recipient has PVT. Preoperatively, anticoagulation remains the mainstay of treatment, with transjugular intrahepatic portosystemic shunt (TIPS) playing an adjunct role in preparing patients for liver transplantation. In all patients, thrombectomy with re-establishment of physiological portal flow is the initial step. In patients where flow cannot be established, other physiological or nonphysiological means are employed, especially in complex PVT. Patients with grade III/IV PVT have worse outcomes (graft failure, mortality, recurrence) than those with lower-grade PVT. Physiological reconstruction is the method of choice, whereas non-physiological means are used as a bailout procedure.
门静脉血栓形成(PVT)在高达15%的肝硬化患者中是肝硬化自然病程的一部分。在最初,PVT被认为是肝移植的禁忌证,但现在随着技术的进步和围手术期管理,复杂PVT患者也能接受活体肝移植(LDLT),且预后相似。本文综述了受体存在PVT时进行肝移植的方法。术前,抗凝仍是主要治疗手段,经颈静脉肝内门体分流术(TIPS)在为患者进行肝移植准备中起辅助作用。对所有患者而言,行血栓切除术并重建生理性门静脉血流是第一步。在无法建立血流的患者中,尤其是复杂PVT患者,采用其他生理性或非生理性手段。III/IV级PVT患者的预后(移植物失败、死亡率、复发率)比低级别PVT患者更差。生理性重建是首选方法,而非生理性手段则用作补救措施。